Literature DB >> 10529540

Clinical characteristics of aged Becker muscular dystrophy patients with onset after 30 years.

M Yazaki1, K Yoshida, A Nakamura, J Koyama, T Nanba, N Ohori, S Ikeda.   

Abstract

To elucidate the clinical characteristics of aged patients with Becker muscular dystrophy (BMD), 4 patients with this disease who were over 50 years were examined. The ages at onset in all patients were later than 30 years. All were proven to have a deletion around exons 45-55 of the Duchenne muscular dystrophy (DMD) gene. Two patients became wheelchair bound in their 40s or beyond, while the other 2 (aged 73 and 69, respectively) were still able to walk at the time of examination. Three of 4 patients had no obvious hypertrophy in their calves, which is known to be one of the characteristic clinical features in the juvenile BMD patients. Serum creatine kinase levels were elevated in all patients, but not markedly (mean 444.8 +/- 230.3 U/l; normal value < 180 U/l). Dilated cardiomyopathy was clinically apparent in 2 patients. We emphasize that some BMD patients are free of muscular symptoms until their 50s and are still self-supporting in their 60s or 70s.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529540     DOI: 10.1159/000008089

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  12 in total

1.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

2.  CRISPR-Induced Deletion with SaCas9 Restores Dystrophin Expression in Dystrophic Models In Vitro and In Vivo.

Authors:  Benjamin L Duchêne; Khadija Cherif; Jean-Paul Iyombe-Engembe; Antoine Guyon; Joel Rousseau; Dominique L Ouellet; Xavier Barbeau; Patrick Lague; Jacques P Tremblay
Journal:  Mol Ther       Date:  2018-08-16       Impact factor: 11.454

3.  Cardiac-Specific Expression of ΔH2-R15 Mini-Dystrophin Normalized All Electrocardiogram Abnormalities and the End-Diastolic Volume in a 23-Month-Old Mouse Model of Duchenne Dilated Cardiomyopathy.

Authors:  Nalinda B Wasala; Jin-Hong Shin; Yi Lai; Yongping Yue; Federica Montanaro; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2018-03-22       Impact factor: 5.695

Review 4.  Gene therapy for muscular dystrophy: lessons learned and path forward.

Authors:  Jerry R Mendell; Louise Rodino-Klapac; Zarife Sahenk; Vinod Malik; Brian K Kaspar; Christopher M Walker; K Reed Clark
Journal:  Neurosci Lett       Date:  2012-05-17       Impact factor: 3.046

5.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Authors:  Kristy Swiderski; Scott A Shaffer; Byron Gallis; Guy L Odom; Andrea L Arnett; J Scott Edgar; Dale M Baum; Annabel Chee; Timur Naim; Paul Gregorevic; Kate T Murphy; James Moody; David R Goodlett; Gordon S Lynch; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

Review 6.  Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy.

Authors:  Kasia Dzierlega; Toshifumi Yokota
Journal:  Gene Ther       Date:  2020-06-01       Impact factor: 5.250

7.  Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.

Authors:  Rita Wen Kaspar; Hugh D Allen; Will C Ray; Carlos E Alvarez; John T Kissel; Alan Pestronk; Robert B Weiss; Kevin M Flanigan; Jerry R Mendell; Federica Montanaro
Journal:  Circ Cardiovasc Genet       Date:  2009-09-30

8.  WGS and RNA Studies Diagnose Noncoding DMD Variants in Males With High Creatine Kinase.

Authors:  Leigh B Waddell; Samantha J Bryen; Beryl B Cummings; Adam Bournazos; Frances J Evesson; Himanshu Joshi; Jamie L Marshall; Taru Tukiainen; Elise Valkanas; Ben Weisburd; Simon Sadedin; Mark R Davis; Fathimath Faiz; Rebecca Gooding; Sarah A Sandaradura; Gina L O'Grady; Michel C Tchan; David R Mowat; Emily C Oates; Michelle A Farrar; Hugo Sampaio; Alan Ma; Katherine Neas; Min-Xia Wang; Amanda Charlton; Charles Chan; Diane N Kenwright; Nicole Graf; Susan Arbuckle; Nigel F Clarke; Daniel G MacArthur; Kristi J Jones; Monkol Lek; Sandra T Cooper
Journal:  Neurol Genet       Date:  2021-01-29

9.  Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin.

Authors:  Hong Wang; Elena Marrosu; Daniel Brayson; Nalinda B Wasala; Eric K Johnson; Charlotte S Scott; Yongping Yue; Kwan-Leong Hau; Aaron J Trask; Stan C Froehner; Marvin E Adams; Liwen Zhang; Dongsheng Duan; Federica Montanaro
Journal:  Hum Mol Genet       Date:  2021-06-26       Impact factor: 6.150

10.  The effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Annemieke Aartsma-Rus
Journal:  PLoS Curr       Date:  2012-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.